BioCryst Pharmaceuticals | BCRX - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Chugai Pharma JPY 107.52B 19.72B 2026-03
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
DBV Technologies USD 39.5M 1.44M 2026-03
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Glaxosmithkline GBP 14.34B 6.39B 2026-03
Incyte USD 228.62M 1.41B 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Novavax USD 16.1M 8.48M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03